Selective intratumoral amplification of an antiangiogenic vector by an oncolytic virus produces enhanced antivascular and anti-tumor efficacy.
暂无分享,去创建一个
[1] R. Samulski,et al. Adeno-associated virus vectors: potential applications for cancer gene therapy , 2005, Cancer Gene Therapy.
[2] C. Barcia,et al. Regulatable gene expression systems for gene therapy applications: progress and future challenges. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[3] Malika Benouchan,et al. Anti-angiogenic strategies for cancer therapy (Review). , 2005, International journal of oncology.
[4] M. Hitt,et al. Transcriptionally targeted adenovirus vectors. , 2005, Current gene therapy.
[5] Daniel W. Pack,et al. Design and development of polymers for gene delivery , 2005, Nature Reviews Drug Discovery.
[6] L. Rosen. VEGF-targeted therapy: therapeutic potential and recent advances. , 2005, The oncologist.
[7] Chryso Kanthou,et al. Disrupting tumour blood vessels , 2005, Nature Reviews Cancer.
[8] Roy Bicknell,et al. Tumour vascular targeting , 2005, Nature Reviews Cancer.
[9] S. Motl. Bevacizumab in combination chemotherapy for colorectal and other cancers. , 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[10] G. Palù,et al. Versatility of gene therapy vectors through viruses , 2005, Expert opinion on biological therapy.
[11] C. Qian,et al. Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[12] C. Kuo,et al. Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy , 2005, Cancer Gene Therapy.
[13] R. Jain. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.
[14] D. Carbone,et al. Combination Therapy with Conditionally Replicating Adenovirus and Replication Defective Adenovirus , 2004, Cancer Research.
[15] D. Kirn,et al. Ablating CAR and integrin binding in adenovirus vectors reduces nontarget organ transduction and permits sustained bloodstream persistence following intraperitoneal administration. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[16] D. Waxman,et al. Use of Replication-Conditional Adenovirus as a Helper System to Enhance Delivery of P450 Prodrug-Activation Genes for Cancer Therapy , 2004, Cancer Research.
[17] J. Bell,et al. Getting oncolytic virus therapies off the ground. , 2003, Cancer cell.
[18] I. Kuhn,et al. Armed therapeutic viruses: Strategies and challenges to arming oncolytic viruses with therapeutic genes , 2002, Cancer Gene Therapy.
[19] T. Hermiston. Fighting fire with fire: attacking the complexity of human tumors with armed therapeutic viruses. , 2002, Current opinion in molecular therapeutics (Print).
[20] P. Seth,et al. Adenovirus replication–competent vectors (KD1, KD3) complement the cytotoxicity and transgene expression from replication-defective vectors (Ad-GFP, Ad-Luc) , 2002, Cancer Gene Therapy.
[21] M. Halterman,et al. A novel approach to cancer therapy using an oncolytic herpes virus to package amplicons containing cytokine genes. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[22] R. Martuza,et al. Replication-selective virotherapy for cancer: Biological principles, risk management and future directions , 2001, Nature Medicine.
[23] R. D'Amato,et al. Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] L. Johnson,et al. An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy , 2000, Nature Medicine.
[25] T. Hermiston. Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer. , 2000, The Journal of clinical investigation.
[26] E. Harlow,et al. Cellular targets for transformation by the adenovirus E1A proteins , 1989, Cell.
[27] G. Winberg,et al. Dissection of overlapping functions within the adenovirus type 5 E1A gene. , 1984, The EMBO journal.
[28] Xian-Yang Zhang,et al. LSU Digital Commons LSU Digital Commons Altering the tropism of lentiviral vectors through pseudotyping Altering the tropism of lentiviral vectors through pseudotyping , 2022 .